Pellitorine
CAS No. 18836-52-7
Pellitorine( AI3-19560 | Pellitorin | Pellitorine )
Catalog No. M27373 CAS No. 18836-52-7
Pellitorine is an extract of Tetradium daniellii, and acts as a TRPV1 antagonist.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 5MG | 357 | Get Quote |
|
| 10MG | 530 | Get Quote |
|
| 25MG | 851 | Get Quote |
|
| 50MG | 1152 | Get Quote |
|
| 100MG | Get Quote | Get Quote |
|
| 200MG | Get Quote | Get Quote |
|
| 500MG | Get Quote | Get Quote |
|
| 1G | Get Quote | Get Quote |
|
Biological Information
-
Product NamePellitorine
-
NoteResearch use only, not for human use.
-
Brief DescriptionPellitorine is an extract of Tetradium daniellii, and acts as a TRPV1 antagonist.
-
DescriptionPellitorine is an extract of Tetradium daniellii, and acts as a TRPV1 antagonist.
-
In Vitro——
-
In Vivo——
-
SynonymsAI3-19560 | Pellitorin | Pellitorine
-
PathwayMembrane Transporter/Ion Channel
-
TargetTRP/TRPV Channel
-
RecptorNR1A-NMDA|NR2B-NMDA
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number18836-52-7
-
Formula Weight223.36
-
Molecular FormulaC14H25NO
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 50 mg/mL (223.86 mM)
-
SMILESCCCCC\C=C\C=C\C(=O)NCC(C)C
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
-
TRPM8 antagonist 3
TRPM8 antagonist 3 is a blocker of TRPM8 (IC50 = 11 nM).
-
Pyr10
Pyr10 is a pyrazole derivative and a selective TRP cation 3 inhibitor. Pyr10 has the ability to distinguish between receptor-operated TRPC3 and native stromal interaction molecule 1 (STIM1)/Orai1 channels. Pyr10 inhibits Ca2+ influx in carbachol-stimulated TRPC3-transfected HEK293 cells (IC50: 0.72 μM) (IC50 of 13.08 μM for store-operated Ca2+ entry in BRL-2H3 cells) .
-
Pinokalant
Pinokalant (LOE-908) is a novel non-selective cation channel inhibitor.Pinokalant significantly reduces cortical infarct volume in in vivo experiments, improves the metabolic and electrophysiological status of the ischemic penumbra region.
Cart
sales@molnova.com